KPC Pharmaceuticals Inc
SSE:600422

Watchlist Manager
KPC Pharmaceuticals Inc Logo
KPC Pharmaceuticals Inc
SSE:600422
Watchlist
Price: 15.25 CNY -2.49% Market Closed
Market Cap: 11.5B CNY
Have any thoughts about
KPC Pharmaceuticals Inc?
Write Note

Relative Value

The Relative Value of one KPC Pharmaceuticals Inc stock under the Base Case scenario is 27.46 CNY. Compared to the current market price of 15.25 CNY, KPC Pharmaceuticals Inc is Undervalued by 44%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
27.46 CNY
Undervaluation 44%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
28
vs Industry
57
Median 3Y
1.5
Median 5Y
1
Industry
2.6
Forward
1.3
vs History
34
vs Industry
15
Median 3Y
27.5
Median 5Y
20.1
Industry
23
Forward
20.4
vs History
85
vs Industry
25
Median 3Y
44.4
Median 5Y
36
Industry
17.8
vs History
69
vs Industry
24
Median 3Y
31.7
Median 5Y
22.8
Industry
25.4
vs History
34
vs Industry
32
Median 3Y
2.3
Median 5Y
1.9
Industry
2.2
vs History
30
vs Industry
58
Median 3Y
1.5
Median 5Y
1
Industry
2.8
Forward
1.3
vs History
30
vs Industry
50
Median 3Y
3.5
Median 5Y
2.5
Industry
5.4
vs History
36
vs Industry
16
Median 3Y
21.1
Median 5Y
15.8
Industry
13.7
Forward
12.7
vs History
36
vs Industry
19
Median 3Y
21.1
Median 5Y
15.8
Industry
17.2
Forward
14.1
vs History
84
vs Industry
26
Median 3Y
42.1
Median 5Y
34.6
Industry
16.5
vs History
65
vs Industry
22
Median 3Y
20.1
Median 5Y
21.9
Industry
19.3
vs History
34
vs Industry
39
Median 3Y
1.6
Median 5Y
1.3
Industry
2

Multiples Across Competitors

Competitors Multiples
KPC Pharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
KPC Pharmaceuticals Inc
SSE:600422
11.5B CNY 1.5 25.6 19.1 19.1
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
761.8B USD 18.5 90.9 48.9 54.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
368.4B USD 4.2 25 12.1 15.8
US
Merck & Co Inc
NYSE:MRK
250.9B USD 4 20.6 10.4 12.5
CH
Roche Holding AG
SIX:ROG
208.8B CHF 3.6 18.2 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.2B CHF 4.2 12.6 10 14.9
UK
AstraZeneca PLC
LSE:AZN
158.6B GBP 4.1 31.3 169.3 253.7
IE
Endo International PLC
LSE:0Y5F
155B USD 66.9 -53 248.3 622.6
P/E Multiple
Earnings Growth
CN
KPC Pharmaceuticals Inc
SSE:600422
Average P/E: 32.4
25.6
101%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
90.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25
-22%
US
Merck & Co Inc
NYSE:MRK
20.6
7 336%
CH
Roche Holding AG
SIX:ROG
18.2
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.3
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -53 N/A

See Also

Discover More
Back to Top